- Oops!Something went wrong.Please try again later.
Investors are digesting exactly why control of so many voting shares was just given up by a key founder.
You don't have to settle for boring old dividend stocks to fit that purpose. Three stocks to put on your list if you're a buy-and-hold investor are Abbott Laboratories (NYSE: ABT), Palantir Technologies (NYSE: PLTR), and Walmart (NYSE: WMT). Abbott Laboratories is a robust healthcare business that makes for an ideal set-and-forget investment.
When you buy a stock, the worst thing that can happen is that you lose 100% of your investment. Of course, that's not a great outcome, but the downside is smaller than the upside. In other words, when you buy a stock, the upside doesn't stop at 100%.
Congressional Democrats want to slam shut a tax loophole known as the “backdoor” Roth IRA. In one of several proposed changes that target the retirement accounts of wealthy Americans, Democrats on the House Ways and Means Committee want to prohibit people … Continue reading → The post Democrats Want to End This Lucrative Retirement Account Loophole appeared first on SmartAsset Blog.
"The interest from the public has surpassed our highest expectations," Executive Chairman Bill Ford said in a statement. Ford's move, confirming a Reuters report last month, comes even as Industry observers question whether individual buyers will give up their gas-powered pickups for electric models. The Lightning is an electric version of Ford's best-selling gas-powered F-150 truck, whose popularity has made it the subject of some songs.
Wynn Resorts and Las Vegas Sands have tumbled. Analysts say the firms may face tougher regulations but will survive, and that their shares could be bargains.
The market has written off these two high-quality stocks, but both could complement an income investor's portfolio.
Shares of satellite communications company Globalstar (NYSEMKT: GSAT) crashed 21% yesterday after it became apparent that Apple's (NASDAQ: AAPL) new iPhone 13 will in fact not enable users to call each other via satellite. In the absence of any actual "good" news to explain the stock's bounce higher, I can only surmise that what we're looking at today is a "dead cat bounce." The way they would have placed that bet would have been by shorting Globalstar stock (i.e., selling stock they did not own, in hopes of buying it back later, cheaper, and returning the shares to their rightful owners).
Benjamin Graham once said: "In the short run, the market is a voting machine but in the long run, it is a weighing machine." It means that sentiment drives stock prices at any given moment, but over a span of many years, the price will reflect the actual value created by the business. In some cases, it's hard to find a rationale for a stock price that conforms to reality.
Cell biology specialist Berkeley Lights (NASDAQ: BLI) was getting slammed by investors on Wednesday, following a scathing tweet from an institutional short-seller. A firm called Scorpion Capital, which describes itself as focused on "activist short selling" of businesses it considers dubious, thrashed Berkeley Lights in a tweet thread published Wednesday morning. In the thread, Scorpion Capital forcefully accused the company of "Fleecing Customers And IPO Bagholders With A $2 [million] Black Box That's A Clunker."
The most far-reaching part of Democrats' proposal within the $3.5 trillion reconciliation package is the requirement for many businesses to offer a retirement plan for their workers.
Read more to find out why we think Novavax (NASDAQ: NVAX), Sorrento Therapeutics (NASDAQ: SRNE), and InMode (NASDAQ: INMD) will close out 2021 with a bang. Taylor Carmichael (Novavax): Novavax stock has already doubled this year, running from $112 back in January to $233 this week. Right now, Moderna enjoys a $169 billion market cap, and BioNTech sports a $79 billion valuation.
More news today from Chinese officials has investors fearing what might be next for U.S.-traded Chinese companies.
Aerie Pharmaceuticals Inc (NASDAQ: AERI) announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry eye disease. The company said that the study failed to achieve statistical significance at pre-determined primary endpoints at Day 28. However, the ophthalmic solution reached statistical significance over multiple pre-specified symptoms and signs, Aerie added. Aerie observed the most significant efficacy in the higher concentration, and
Demand for refis continues to fall because homeowners are making this risky bet.
If this is because business prospects have worsened, the dividend is at risk. Based on these stocks' yields, you should just about double your money on the dividends alone, as long as you reinvest them at the same rate. Add in the potential for stock price appreciation, and these high-risk stocks could provide you with a nice reward in a decade.
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
With the Nasdaq Composite still flirting with its all-time highs, investors might be surprised to find some technology stocks are actually trading at relative bargain valuations. Zendesk (NYSE: ZEN), Teladoc (NYSE: TDOC), and Zoom Video(NASDAQ: ZM) all have great products and sound strategies that should make them winners over the long term. Right now, though, they are in Wall Street's doghouse.
More than a trillion dollars could be flowing into infrastructure spending and these companies could be big winners if Congress passes an infrastructure bill.
One strategy for selecting top stocks is to follow a known market guru, a high-profile, highly successful investor. These are the pros who have built multi-billion dollar portfolios, and manage the high-performing hedge funds. And ARK Investing’s Cathie Wood stands tall in their ranks. How successful? Well, last year, her $21.1 billion ARK Innovation fund led the way among the best-performing actively managed equity funds in the US. In recent days, Wood has been making some waves by noting that
With the business potentially at an important milestone, we thought we'd take a closer look at Bloom Energy...